Hiroki Yamaue

41PUBLICATIONS
114CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesPredictive and prognostic markersSurgeryCivil procedure
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Sep 04, 2024
Is multidisciplinary treatment effective for invasive intraductal papillary mucinous carcinoma?

Seiko Hirono, Ryota Higuchi, Goro Honda

|Aug 16, 2024
Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1).

Naohiro Okano, Manabu Kawai, Makoto Ueno

|May 31, 2024
Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea.

Yasuhiro Yabushita, Joon Seong Park, Yoo-Seok Yoon

|Nov 06, 2023
Efficacy and safety of neoadjuvant nab-paclitaxel plus gemcitabine therapy in patients with borderline resectable pancreatic cancer: A multicenter single-arm phase II study (NAC-GA trial).

Ken-Ichi Okada, Kenjiro Kimura, Yo-Ichi Yamashita

|Oct 04, 2023
Central pancreatectomy might be an acceptable surgical procedure for clinical T1 pancreatic body ductal adenocarcinoma: A multicenter retrospective analysis.

Taichi Terai, Manabu Kawai, Yuji Kitahata

|Sep 02, 2023
Impact of antithrombotic therapy on postpancreatectomy hemorrhage in 7116 patients: A project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Kota Nakamura, Minako Nagai, Ippei Matsumoto

Pageof 7

Frequent Collaborators

13 joint publications

Itaru Endo

8 joint publications

Ippei Matsumoto

6 joint publications

Sohei Satoi

6 joint publications

Michiaki Unno